Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
ORILISSA ABBVIE CORPORATION Actual shortage 150MG Updated Report 2025-01-22 245357
DUAVIVE PFIZER CANADA ULC Actual shortage 20MG 0.45MG Updated Report 2025-01-22 235491
DEPO-MEDROL 40 MG/ML PFIZER CANADA ULC Actual shortage 40MG Updated Report 2025-01-22 232321
XYLOCAINE 2% ASPEN PHARMACARE CANADA INC. Actual shortage 20MG Updated Report 2025-01-22 247180
XYLOCAINE 1% ASPEN PHARMACARE CANADA INC. Actual shortage 10MG Updated Report 2025-01-22 247177
TOBRAMYCIN FOR INJECTION FRESENIUS KABI CANADA LTD Resolved 1.2G Updated Report 2025-01-22 245141
TRANDOLAPRIL SANIS HEALTH INC Anticipated shortage 1MG Updated Report 2025-01-22 247555
PERINDOPRIL/INDAPAMIDE SANIS HEALTH INC Anticipated shortage 2.5MG 8MG Updated Report 2025-01-22 243716
PERINDOPRIL ERBUMINE SANIS HEALTH INC Actual shortage 4MG Updated Report 2025-01-22 243707
MOXIFLOXACIN SANIS HEALTH INC Actual shortage 400MG Updated Report 2025-01-22 228981

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
TARO-ZOLEDRONIC ACID TARO PHARMACEUTICALS INC Discontinued 5MG New Report 2025-01-21 248172
CABLIVI SANOFI-AVENTIS CANADA INC Discontinued 11MG New Report 2025-01-17 248053
CABLIVI SANOFI-AVENTIS CANADA INC Discontinued 11MG New Report 2025-01-16 247940
ELAVIL AA PHARMA INC To be discontinued 75MG New Report 2025-01-16 247842
ELAVIL AA PHARMA INC To be discontinued 50MG New Report 2025-01-16 247839